- Home
- OSRH vs ERNA Comparison
OSRH vs ERNA Comparison
Compare OSRH & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSRH
- ERNA
- Stock Information
- Founded
- OSRH N/A
- ERNA 2018
- Country
- OSRH United States
- ERNA United States
- Employees
- OSRH N/A
- ERNA N/A
- Industry
- OSRH
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- OSRH
- ERNA Health Care
- Exchange
- OSRH Nasdaq
- ERNA Nasdaq
- Market Cap
- OSRH 11.1M
- ERNA 10.2M
- IPO Year
- OSRH N/A
- ERNA N/A
- Fundamental
- Price
- OSRH $0.58
- ERNA $1.26
- Analyst Decision
- OSRH
- ERNA
- Analyst Count
- OSRH 0
- ERNA 0
- Target Price
- OSRH N/A
- ERNA N/A
- AVG Volume (30 Days)
- OSRH 13.8M
- ERNA 45.4K
- Earning Date
- OSRH 08-14-2025
- ERNA 08-13-2025
- Dividend Yield
- OSRH N/A
- ERNA N/A
- EPS Growth
- OSRH N/A
- ERNA N/A
- EPS
- OSRH N/A
- ERNA N/A
- Revenue
- OSRH $104,735.00
- ERNA $488,000.00
- Revenue This Year
- OSRH N/A
- ERNA N/A
- Revenue Next Year
- OSRH N/A
- ERNA N/A
- P/E Ratio
- OSRH N/A
- ERNA N/A
- Revenue Growth
- OSRH N/A
- ERNA 201.24
- 52 Week Low
- OSRH $0.45
- ERNA $1.21
- 52 Week High
- OSRH $13.40
- ERNA $26.60
- Technical
- Relative Strength Index (RSI)
- OSRH 41.12
- ERNA 30.36
- Support Level
- OSRH $0.74
- ERNA $1.43
- Resistance Level
- OSRH $1.24
- ERNA $1.47
- Average True Range (ATR)
- OSRH 0.11
- ERNA 0.12
- MACD
- OSRH 0.01
- ERNA -0.01
- Stochastic Oscillator
- OSRH 15.50
- ERNA 9.18
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.